Cost-effectiveness of enzyme replacement therapy with alglucosidase alfa in classic-infantile patients with Pompe disease

Cost-effectiveness of enzyme replacement therapy with alglucosidase alfa in classic-infantile patients with Pompe disease

10.1186/1750-1172-9-75

Saved in:

Bibliographic Details
Main Authors:	Kanters, T.A, Hoogenboom-Plug, I, Rutten-Van Mölken, M.P, Redekop, W.K, Van Der Ploeg, A.T, Hakkaart, L
Other Authors:	SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH
Format:	Article
Published:	2020
Subjects:	recombinant glucan 1,4 alpha glucosidase alpha glucosidase GAA protein, human adolescent adult article child cost effectiveness analysis enzyme replacement female glycogen storage disease type 2 health care cost health care utilization hospital cost human life expectancy major clinical study male middle aged preschool child quality adjusted life year quality of life school child survival teaching young adult cost benefit analysis drug cost economics Glycogen Storage Disease Type II infant newborn pathophysiology alpha-Glucosidases Cost-Benefit Analysis Drug Costs Enzyme Replacement Therapy Humans Infant Infant, Newborn Patient Simulation Quality of Life
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/181757
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Description
Summary:	10.1186/1750-1172-9-75